Literature DB >> 10644400

Haemolytic anaemia due to metformin.

A S Kashyap1, S Kashyap.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10644400      PMCID： PMC1741489          DOI： 10.1136/pmj.76.892.125

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  7 in total

1.  Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.

Authors:  James F Crismale; Valérie Martel-Laferrière; Kian Bichoupan; Emily Schonfeld; Alexis Pappas; Christina Wyatt; Joseph A Odin; Lawrence U Liu; Thomas D Schiano; Ponni V Perumalswami; Meena Bansal; Douglas T Dieterich; Andrea D Branch
Journal:  Liver Int       Date:  2013-10-25       Impact factor: 5.828

2.  Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma.

Authors:  Franck Laporte; Safouane Hamdi; Françoise Oksman; Françoise Huguet
Journal:  Pharm World Sci       Date:  2008-04-05

3.  Metformin: an old but still the best treatment for type 2 diabetes.

Authors:  Lilian Beatriz Aguayo Rojas; Marilia Brito Gomes
Journal:  Diabetol Metab Syndr       Date:  2013-02-15       Impact factor: 3.320

4.  Metformin poisoning: A complex presentation.

Authors:  Manish Jagia; Salah Taqi; Mahmud Hanafi
Journal:  Indian J Anaesth       Date:  2011-03

5.  Severe hemolysis with negative direct antiglobulin test: A case report.

Authors:  Mahin Behzadifard; Ali Arianezhad; Ali Bandehzadeh; Mohammadali Gholampour
Journal:  Ann Med Surg (Lond)       Date:  2022-08-18

6.  Fatal hemolytic anemia associated with metformin: a case report.

Authors:  Clifford D Packer; Thomas R Hornick; Sarah A Augustine
Journal:  J Med Case Rep       Date:  2008-09-10

7.  Metformin-induced hemolytic anemia.

Authors:  Serap Kirkiz; Nese Yarali; Ozlem Arman Bilir; Bahattin Tunc
Journal:  Med Princ Pract       Date:  2013-11-27       Impact factor: 1.927
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.